People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vizgen, Inc. | — | Biotechnology | Series D+ | $295.1M | $320.2M | 2024 |
| Ultivue, Inc. | — | Biotechnology | Series B | $55.2M | $23.4M | 2024 |
| Axis Semiconductor Inc | — | Other Technology | Seed | $4.0M | $34.1M | 2009 |
Robert Carson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert Carson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Keith Crandell | 2 | 11 |
| Andrea Jackson | 2 | 6 |
| Ray Stata | 1 | 7 |
| David Walt | 1 | 6 |
| Marc Dupre | 1 | 6 |
| David R. Walt | 1 | 5 |
| Matthew Posard | 1 | 4 |
| Michael Natan | 1 | 3 |
| Peng Yin | 1 | 3 |
| Fenel Eloi | 1 | 3 |
| Andrew Stevenson | 1 | 2 |
| Marijn E. Dekkers | 1 | 2 |
| Philip Gardella | 1 | 2 |
| Wen R. Chen | 1 | 1 |
| Sharon Yong Kedar | 1 | 1 |
| Xiaolin Wang | 1 | 1 |
| Qian Wu | 1 | 1 |
| Peng R. Ying | 1 | 1 |
| Simona Levi | 1 | 1 |
| Christian Uhrich | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.